SGLT2 inhibitors: β blockers for the kidney?
Lancet Diabetes Endocrinol
.
2016 Oct;4(10):814.
doi: 10.1016/S2213-8587(16)30237-6.
Author
Richard E Gilbert
1
Affiliation
1
Division of Endocrinology, University of Toronto, St Michael's Hospital, ON, Canada. Electronic address: richard.gilbert@utoronto.ca.
PMID:
27663956
DOI:
10.1016/S2213-8587(16)30237-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenergic beta-Antagonists
Diabetes Mellitus, Type 2
Humans
Hypoglycemic Agents
Kidney*
Sodium-Glucose Transporter 2*
Substances
Adrenergic beta-Antagonists
Hypoglycemic Agents
Sodium-Glucose Transporter 2